CH AGRI-PROD EX (00149) Income Statement & Earnings

0.063
-0.004-5.97%

Market Closed Apr 30 15:59 CST

627.04MMarket Cap63.00P/E (TTM)

CH AGRI-PROD EX (00149) Income Statement

All

YOY

Hide blank lines

(Q6)Sep 30, 2025

(FY)Mar 31, 2025

(Q6)Sep 30, 2024

(FY)Mar 31, 2024

(Q6)Sep 30, 2023

(FY)Mar 31, 2023

(Q6)Sep 30, 2022

(FY)Mar 31, 2022

(Q6)Sep 30, 2021

(FY)Mar 31, 2021

Turnover

-37.50%189.44M

-8.35%530.76M

-6.65%303.09M

-2.90%579.13M

0.99%324.69M

-31.34%596.4M

-21.92%321.51M

33.54%868.69M

40.83%411.79M

-40.40%650.53M

Operating income

-37.50%189.44M

-8.35%530.76M

-6.65%303.09M

-2.90%579.13M

0.99%324.69M

-31.34%596.4M

-21.92%321.51M

33.54%868.69M

40.83%411.79M

-40.40%650.53M

Cost of sales

65.57%-56.16M

0.62%-234.37M

-0.49%-163.12M

11.22%-235.84M

-14.77%-162.32M

35.60%-265.64M

23.09%-141.43M

-38.09%-412.5M

-29.70%-183.89M

45.93%-298.72M

Operating expenses

65.57%-56.16M

0.62%-234.37M

-0.49%-163.12M

11.22%-235.84M

-14.77%-162.32M

35.60%-265.64M

23.09%-141.43M

-38.09%-412.5M

-29.70%-183.89M

45.93%-298.72M

Gross profit

-4.78%133.28M

-13.66%296.39M

-13.80%139.97M

3.79%343.29M

-9.83%162.37M

-27.49%330.77M

-20.98%180.08M

29.67%456.19M

51.30%227.9M

-34.72%351.81M

Selling expenses

64.45%-4.85M

49.96%-18.2M

12.46%-13.63M

22.70%-36.37M

5.33%-15.57M

22.95%-47.05M

29.76%-16.44M

-99.83%-61.07M

-60.25%-23.41M

68.56%-30.56M

Administrative expenses

9.82%-75.4M

-5.51%-169.61M

-6.23%-83.62M

1.81%-160.75M

3.64%-78.71M

-9.99%-163.7M

-9.46%-81.68M

5.47%-148.83M

6.04%-74.62M

21.37%-157.44M

Profit from asset sales

----

---22.19M

----

Revaluation surplus

251.44%12.91M

84.91%-12.46M

-419.45%-8.52M

-1,620.32%-82.56M

-89.17%2.67M

91.03%-4.8M

593.58%24.64M

-269.64%-53.49M

-90.93%3.55M

-109.84%-14.47M

-Changes in the fair value of investment property

258.66%12.93M

85.44%-12.04M

-397.66%-8.15M

-1,677.64%-82.68M

-88.88%2.74M

91.30%-4.65M

598.13%24.62M

-276.55%-53.48M

-91.06%3.53M

-109.54%-14.2M

-Changes in the fair value of derivative financial instruments

----

77.57%-59K

80.84%-59K

85.28%-263K

-Changes in the fair value of financial assets

94.95%-19K

-448.33%-418K

-444.93%-376K

181.08%120K

-630.77%-69K

-421.74%-148K

-84.52%13K

866.67%46K

1,150.00%84K

-200.00%-6K

Impairment and provision

119.65%101K

-606.07%-16.18M

8.05%-514K

75.46%-2.29M

89.67%-559K

-15.43%-9.34M

19.34%-5.41M

81.91%-8.09M

-372.39%-6.71M

-366.47%-44.72M

-Impairment of property, machinery and equipment

----

54.39%-2.92M

----

---6.4M

---4.69M

----

41.16%-1.75M

-Other impairment is provision

119.65%101K

-2,675.80%-16.18M

8.05%-514K

121.39%628K

23.00%-559K

63.70%-2.94M

89.18%-726K

81.18%-8.09M

-2,593.68%-6.71M

-549.37%-42.97M

Special items of operating profit

-81.21%8.01M

-64.58%47.24M

66.26%42.63M

229.51%133.37M

89.35%25.64M

-46.21%40.47M

72.41%13.54M

-89.20%75.24M

-23.91%7.86M

3,458.09%696.92M

Operating profit

-2.98%74.05M

-34.67%127.18M

-20.37%76.32M

33.03%194.69M

-16.45%95.84M

-38.45%146.35M

-14.75%114.72M

-70.34%237.76M

28.57%134.57M

101.12%801.55M

Financing cost

16.13%-39.65M

17.93%-91.58M

18.46%-47.28M

5.80%-111.58M

10.37%-57.98M

10.25%-118.45M

2.17%-64.69M

15.99%-131.97M

19.83%-66.13M

30.72%-157.09M

Earning before tax

18.43%34.4M

-57.16%35.61M

-23.29%29.04M

197.88%83.12M

-24.32%37.86M

-73.62%27.9M

-26.90%50.03M

-83.58%105.79M

208.57%68.44M

275.12%644.46M

Tax

-420.92%-15.91M

93.81%-3.48M

86.13%-3.05M

-498.18%-56.24M

25.53%-22.02M

86.33%-9.4M

14.26%-29.57M

52.02%-68.76M

15.42%-34.49M

-3.48%-143.29M

After-tax profit from continuing operations

-28.86%18.49M

19.54%32.13M

64.08%25.99M

45.27%26.88M

-22.58%15.84M

-50.05%18.5M

-39.74%20.46M

-92.61%37.04M

282.63%33.95M

1,403.89%501.17M

Earning after tax

-28.86%18.49M

19.54%32.13M

64.08%25.99M

45.27%26.88M

-22.58%15.84M

-50.05%18.5M

-39.74%20.46M

-92.61%37.04M

282.63%33.95M

1,403.89%501.17M

Minority profit

-32.10%10.67M

24.44%24.29M

100.24%15.71M

67.36%19.52M

-38.21%7.85M

-61.92%11.67M

-18.92%12.7M

164.83%30.64M

293.96%15.66M

-57.85%11.57M

Profit attributable to shareholders

-23.92%7.82M

6.53%7.83M

28.59%10.28M

7.56%7.35M

2.98%8M

6.80%6.84M

-57.56%7.76M

-98.69%6.4M

181.07%18.29M

8,226.56%489.6M

Basic earnings per share

-20.00%0.0008

14.29%0.0008

25.00%0.001

0.00%0.0007

0.00%0.0008

16.67%0.0007

-55.56%0.0008

-98.78%0.0006

178.26%0.0018

8,100.00%0.0492

Diluted earnings per share

-20.00%0.0008

14.29%0.0008

25.00%0.001

0.00%0.0007

0.00%0.0008

16.67%0.0007

-55.56%0.0008

-98.78%0.0006

178.26%0.0018

8,083.33%0.0491

Currency Unit

HKD

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

National Health Accounting Firm Co., Ltd.

	(Q6)Sep 30, 2025	(FY)Mar 31, 2025	(Q6)Sep 30, 2024	(FY)Mar 31, 2024	(Q6)Sep 30, 2023	(FY)Mar 31, 2023	(Q6)Sep 30, 2022	(FY)Mar 31, 2022	(Q6)Sep 30, 2021	(FY)Mar 31, 2021
Turnover	-37.50%189.44M	-8.35%530.76M	-6.65%303.09M	-2.90%579.13M	0.99%324.69M	-31.34%596.4M	-21.92%321.51M	33.54%868.69M	40.83%411.79M	-40.40%650.53M
Operating income	-37.50%189.44M	-8.35%530.76M	-6.65%303.09M	-2.90%579.13M	0.99%324.69M	-31.34%596.4M	-21.92%321.51M	33.54%868.69M	40.83%411.79M	-40.40%650.53M
Cost of sales	65.57%-56.16M	0.62%-234.37M	-0.49%-163.12M	11.22%-235.84M	-14.77%-162.32M	35.60%-265.64M	23.09%-141.43M	-38.09%-412.5M	-29.70%-183.89M	45.93%-298.72M
Operating expenses	65.57%-56.16M	0.62%-234.37M	-0.49%-163.12M	11.22%-235.84M	-14.77%-162.32M	35.60%-265.64M	23.09%-141.43M	-38.09%-412.5M	-29.70%-183.89M	45.93%-298.72M
Gross profit	-4.78%133.28M	-13.66%296.39M	-13.80%139.97M	3.79%343.29M	-9.83%162.37M	-27.49%330.77M	-20.98%180.08M	29.67%456.19M	51.30%227.9M	-34.72%351.81M
Selling expenses	64.45%-4.85M	49.96%-18.2M	12.46%-13.63M	22.70%-36.37M	5.33%-15.57M	22.95%-47.05M	29.76%-16.44M	-99.83%-61.07M	-60.25%-23.41M	68.56%-30.56M
Administrative expenses	9.82%-75.4M	-5.51%-169.61M	-6.23%-83.62M	1.81%-160.75M	3.64%-78.71M	-9.99%-163.7M	-9.46%-81.68M	5.47%-148.83M	6.04%-74.62M	21.37%-157.44M
Profit from asset sales	----	----	----	----	----	----	----	---22.19M	----	----
Revaluation surplus	251.44%12.91M	84.91%-12.46M	-419.45%-8.52M	-1,620.32%-82.56M	-89.17%2.67M	91.03%-4.8M	593.58%24.64M	-269.64%-53.49M	-90.93%3.55M	-109.84%-14.47M
-Changes in the fair value of investment property	258.66%12.93M	85.44%-12.04M	-397.66%-8.15M	-1,677.64%-82.68M	-88.88%2.74M	91.30%-4.65M	598.13%24.62M	-276.55%-53.48M	-91.06%3.53M	-109.54%-14.2M
-Changes in the fair value of derivative financial instruments	----	----	----	----	----	----	----	77.57%-59K	80.84%-59K	85.28%-263K
-Changes in the fair value of financial assets	94.95%-19K	-448.33%-418K	-444.93%-376K	181.08%120K	-630.77%-69K	-421.74%-148K	-84.52%13K	866.67%46K	1,150.00%84K	-200.00%-6K
Impairment and provision	119.65%101K	-606.07%-16.18M	8.05%-514K	75.46%-2.29M	89.67%-559K	-15.43%-9.34M	19.34%-5.41M	81.91%-8.09M	-372.39%-6.71M	-366.47%-44.72M
-Impairment of property, machinery and equipment	----	----	----	54.39%-2.92M	----	---6.4M	---4.69M	----	----	41.16%-1.75M
-Other impairment is provision	119.65%101K	-2,675.80%-16.18M	8.05%-514K	121.39%628K	23.00%-559K	63.70%-2.94M	89.18%-726K	81.18%-8.09M	-2,593.68%-6.71M	-549.37%-42.97M
Special items of operating profit	-81.21%8.01M	-64.58%47.24M	66.26%42.63M	229.51%133.37M	89.35%25.64M	-46.21%40.47M	72.41%13.54M	-89.20%75.24M	-23.91%7.86M	3,458.09%696.92M
Operating profit	-2.98%74.05M	-34.67%127.18M	-20.37%76.32M	33.03%194.69M	-16.45%95.84M	-38.45%146.35M	-14.75%114.72M	-70.34%237.76M	28.57%134.57M	101.12%801.55M
Financing cost	16.13%-39.65M	17.93%-91.58M	18.46%-47.28M	5.80%-111.58M	10.37%-57.98M	10.25%-118.45M	2.17%-64.69M	15.99%-131.97M	19.83%-66.13M	30.72%-157.09M
Earning before tax	18.43%34.4M	-57.16%35.61M	-23.29%29.04M	197.88%83.12M	-24.32%37.86M	-73.62%27.9M	-26.90%50.03M	-83.58%105.79M	208.57%68.44M	275.12%644.46M
Tax	-420.92%-15.91M	93.81%-3.48M	86.13%-3.05M	-498.18%-56.24M	25.53%-22.02M	86.33%-9.4M	14.26%-29.57M	52.02%-68.76M	15.42%-34.49M	-3.48%-143.29M
After-tax profit from continuing operations	-28.86%18.49M	19.54%32.13M	64.08%25.99M	45.27%26.88M	-22.58%15.84M	-50.05%18.5M	-39.74%20.46M	-92.61%37.04M	282.63%33.95M	1,403.89%501.17M
Earning after tax	-28.86%18.49M	19.54%32.13M	64.08%25.99M	45.27%26.88M	-22.58%15.84M	-50.05%18.5M	-39.74%20.46M	-92.61%37.04M	282.63%33.95M	1,403.89%501.17M
Minority profit	-32.10%10.67M	24.44%24.29M	100.24%15.71M	67.36%19.52M	-38.21%7.85M	-61.92%11.67M	-18.92%12.7M	164.83%30.64M	293.96%15.66M	-57.85%11.57M
Profit attributable to shareholders	-23.92%7.82M	6.53%7.83M	28.59%10.28M	7.56%7.35M	2.98%8M	6.80%6.84M	-57.56%7.76M	-98.69%6.4M	181.07%18.29M	8,226.56%489.6M
Basic earnings per share	-20.00%0.0008	14.29%0.0008	25.00%0.001	0.00%0.0007	0.00%0.0008	16.67%0.0007	-55.56%0.0008	-98.78%0.0006	178.26%0.0018	8,100.00%0.0492
Diluted earnings per share	-20.00%0.0008	14.29%0.0008	25.00%0.001	0.00%0.0007	0.00%0.0008	16.67%0.0007	-55.56%0.0008	-98.78%0.0006	178.26%0.0018	8,083.33%0.0491
Currency Unit	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Ernst & Young	--	Ernst & Young	--	National Health Accounting Firm Co., Ltd.	--	National Health Accounting Firm Co., Ltd.	--	National Health Accounting Firm Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"